79 /100
CRITICAL RISK
Score updated May 29, 2026

SONM — DNA X, Inc. Dilution Risk Tracker

Track SONM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SONM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
25
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
42%
💰 Capital Raise 55%
• Critical: only 2.1 months cash remaining
🔁 Convertible Conversion 40%
• Significant convertible debt: 19% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split 15%
• Only 2 months cash — financial pressure
🔔 Track SONM — Get forecast alerts →

💹 Market Data

Market Cap$6.31M
Shares Outstanding1.49M
Float1.21M
Cash$1.20M
Debt$1.07M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 99.9% shares (2025Q4 vs prior)
3 institutional holders · 301 shares
#1 BANK OF AMERICA CORP /DE/ 199 shares
#2 BARCLAYS PLC 100 shares
#3 DANSKE BANK A/S 2 shares

📉 Short Interest

Short Interest85.4K
Days to Cover2.7
% of Float7.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 15, 2025
xbrl XBRL WARRANT May 12, 2025
8-K/A 8K EVENT Mar 02, 2026
3 FORM3 Feb 20, 2026
4 INSIDER TRANSACTION Feb 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SONM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SONM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SONM
📊 SONM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SONM Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SONM Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.